唐苏苏 - 中国药科大学

个人简介

唐苏苏，博士，副教授，硕士生导师，中国药科大学药学院药理系。2014年毕业于中国药科大学，获得博士学位，研究方向为神经精神药理学。作为课题负责人主持国家自然科学基金青年项目1项（81603113）、江苏省自然科学基金青年项目1项（BK20150705）和中央高校基本科研业务费培育项目1项（2015PY012）；作为骨干成员参与国家自然科学基金面上项目3项（81273497，81573413，81773714）、国家“十二五”重大新药创制项目1项（2012ZX09103-101-007）和江苏省自然科学基金面上项目1项（SBK201320969）等。在国际知名杂志如Brain Behav Immun，Neurobiol Aging，Neuropharmacology，Exp Neuro，Int J Neuropsychopharmacol，Neuroscience等发表SCI收录的论文近30篇。

研究领域

神经精神药理学

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.Tang SS*, Ren Y, Ren XQ, Cao JR, Hong H, Ji H, Hu QH*. ERα and/or ERβ activation ameliorates cognitive impairment, neurogenesis and apoptosis in type 2 diabetes mellitus mice. Exp Neuro, 2019, 311: 33-43.(第一作者和通讯作者) 2.Wu X, Lv YG, Du YF, Hu M, Reed MN, Long Y, Suppiramaniam V, Hong H*, Tang SS*. Inhibitory effect of INT-777 on lipopolysaccharide-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice.Prog Neuropsychopharmacol Biol Psychiatry,2019, 88:360-374. (通讯作者) 3.Tang SS*, Ren Y, Xu LJ, Cao JR, Hong H, Ji H, Hu QH*. Activation of ERα and/or ERβ ameliorates cognitive impairment and apoptosis in streptozotocin-induced diabetic mice. Horm Behav, 2018, 105: 95-103. (第一作者和通讯作者) 4.Wu X, Lv YG, Du YF, Chen F, Reed MN, Hu M, Suppiramaniam V, Tang SS*, Hong H*. Neuroprotective effects of INT-777 against Aβ1-42-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice. Brain Behav Immun, 2018, 73: 533-545. (通讯作者) 5.Wang H, Chen F, Du YF, Long Y, Reed MN, Hu M, Suppiramaniam V, Hong H*, Tang SS*. Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice. Neuropharmacology, 2018, 131:143-153. (通讯作者) 6.Fang SC, Xie H, Chen F, Hu M, Long Y, Sun HB, Kong LY, Hong H*, Tang SS*. Simvastatin ameliorates memory impairment and neurotoxicity in streptozotocin-induced diabetic mice. Neuroscience, 2017, 355:200-211. (通讯作者) 7.Tang SS, Ji MJ, Chen L, Hu M, Long Y, Li YQ, Miao MX, Li JC, Li N, Ji H, Chen XJ, Hong H*. Protective effect of pranlukast on Aβ1-42-induced cognitive deficits associated with downregulation of cysteinyl leukotriene receptor 1. Int J Neuropsychopharmacol, 2014, 17(4): 581-592. (第一作者) 8.Tang SS, Hong H*, Chen L, Mei ZL, Ji MJ, Xiang GQ, Li N, Ji H*. Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo. Neurobiol Aging, 2014, 35(3): 590-599. (第一作者)